jak2 selective inhibitor Search Results


90
S*BIO Pte Ltd jak2 inhibitor sb1518
Domain structure of JAK protein family members. JH: Jak homology domains: functional regions are highlighted and include a FERM (Band4.1 ezrin radixin moesin) domain that mediates cytokine receptor binding, an SH2 (Src homology 2) domain and two kinase domains of which only the second is functional. The V617F mutation found in <t>JAK2</t> is lies within the enzymatically inactive pseudo kinase domain.
Jak2 Inhibitor Sb1518, supplied by S*BIO Pte Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2 inhibitor sb1518/product/S*BIO Pte Ltd
Average 90 stars, based on 1 article reviews
jak2 inhibitor sb1518 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Celgene jak2 inhibitor fedratinib
Domain structure of JAK protein family members. JH: Jak homology domains: functional regions are highlighted and include a FERM (Band4.1 ezrin radixin moesin) domain that mediates cytokine receptor binding, an SH2 (Src homology 2) domain and two kinase domains of which only the second is functional. The V617F mutation found in <t>JAK2</t> is lies within the enzymatically inactive pseudo kinase domain.
Jak2 Inhibitor Fedratinib, supplied by Celgene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2 inhibitor fedratinib/product/Celgene
Average 90 stars, based on 1 article reviews
jak2 inhibitor fedratinib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Almirall Hermal jak2/3 inhibitor
Domain structure of JAK protein family members. JH: Jak homology domains: functional regions are highlighted and include a FERM (Band4.1 ezrin radixin moesin) domain that mediates cytokine receptor binding, an SH2 (Src homology 2) domain and two kinase domains of which only the second is functional. The V617F mutation found in <t>JAK2</t> is lies within the enzymatically inactive pseudo kinase domain.
Jak2/3 Inhibitor, supplied by Almirall Hermal, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2/3 inhibitor/product/Almirall Hermal
Average 90 stars, based on 1 article reviews
jak2/3 inhibitor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Celon Pharma selective jak2 inhibitors
Domain structure of JAK protein family members. JH: Jak homology domains: functional regions are highlighted and include a FERM (Band4.1 ezrin radixin moesin) domain that mediates cytokine receptor binding, an SH2 (Src homology 2) domain and two kinase domains of which only the second is functional. The V617F mutation found in <t>JAK2</t> is lies within the enzymatically inactive pseudo kinase domain.
Selective Jak2 Inhibitors, supplied by Celon Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/selective jak2 inhibitors/product/Celon Pharma
Average 90 stars, based on 1 article reviews
selective jak2 inhibitors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Domain structure of JAK protein family members. JH: Jak homology domains: functional regions are highlighted and include a FERM (Band4.1 ezrin radixin moesin) domain that mediates cytokine receptor binding, an SH2 (Src homology 2) domain and two kinase domains of which only the second is functional. The V617F mutation found in JAK2 is lies within the enzymatically inactive pseudo kinase domain.

Journal: The Open Rheumatology Journal

Article Title: JAK Kinases in Health and Disease: An Update

doi: 10.2174/1874312901206010232

Figure Lengend Snippet: Domain structure of JAK protein family members. JH: Jak homology domains: functional regions are highlighted and include a FERM (Band4.1 ezrin radixin moesin) domain that mediates cytokine receptor binding, an SH2 (Src homology 2) domain and two kinase domains of which only the second is functional. The V617F mutation found in JAK2 is lies within the enzymatically inactive pseudo kinase domain.

Article Snippet: Several companies have generated putatively selective JAK2 inhibitors, which are being tested in these disorders including AZD1480, S*BIO (SB1518), Exelixis (XL019) and TargeGen (TG101348) [ - ].

Techniques: Functional Assay, Binding Assay, Mutagenesis

Effect of Mutations in Jak Family Genes in Humans and Mice

Journal: The Open Rheumatology Journal

Article Title: JAK Kinases in Health and Disease: An Update

doi: 10.2174/1874312901206010232

Figure Lengend Snippet: Effect of Mutations in Jak Family Genes in Humans and Mice

Article Snippet: Several companies have generated putatively selective JAK2 inhibitors, which are being tested in these disorders including AZD1480, S*BIO (SB1518), Exelixis (XL019) and TargeGen (TG101348) [ - ].

Techniques:

Clinical Trials Involving the Use of Jak  Inhibitors

Journal: The Open Rheumatology Journal

Article Title: JAK Kinases in Health and Disease: An Update

doi: 10.2174/1874312901206010232

Figure Lengend Snippet: Clinical Trials Involving the Use of Jak Inhibitors

Article Snippet: Several companies have generated putatively selective JAK2 inhibitors, which are being tested in these disorders including AZD1480, S*BIO (SB1518), Exelixis (XL019) and TargeGen (TG101348) [ - ].

Techniques: Clinical Proteomics